32
https://pubmed.ncbi.nlm.nih.gov/38092952
The TAM receptor family’s dysregulation plays a crucial role in disease progression, and while multiple TAM receptor inhibitors are in development, challenges persist in fully realizing their therapeutic potential for cancer and other diseases.
